Avycaz 2.5 GM Injection

RxCUI: 1603845
RxNorm name: Avycaz 2.5 GM Injection
Display name: Avycaz 2.5 GM Injection
Full name: Avycaz 2.5 GM Injection
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:23

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
AVYCAZ	CEFTAZIDIME, AVIBACTAM	Allergan, Inc.	d9c2803f-dc9c-4b19-b4a3-8303bc8c15fd	2025-04-25	Warnings, Adverse reactions	Exact identifier rxcui: 1603845

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
d9c2803f-dc9c-4b19-b4a3-8303bc8c15fd	Avycaz 2.5 GM Injection	PSN	24	These highlights do not include all the information needed to use AVYCAZ ® safely and effectively. See full prescribing information for AVYCAZ . AVYCAZ (ceftazidime and avibactam) for i njection, for intravenous use Initial U.S. Approval: 2015	20250425
d9c2803f-dc9c-4b19-b4a3-8303bc8c15fd	avibactam 500 MG / ceftazidime 2000 MG Injection [Avycaz]	SBD	24	These highlights do not include all the information needed to use AVYCAZ ® safely and effectively. See full prescribing information for AVYCAZ . AVYCAZ (ceftazidime and avibactam) for i njection, for intravenous use Initial U.S. Approval: 2015	20250425
d9c2803f-dc9c-4b19-b4a3-8303bc8c15fd	Avycaz (ceftazidime / avibactam) 2.5 GM Injection	SY	24	These highlights do not include all the information needed to use AVYCAZ ® safely and effectively. See full prescribing information for AVYCAZ . AVYCAZ (ceftazidime and avibactam) for i njection, for intravenous use Initial U.S. Approval: 2015	20250425